Cronos Group Inc vs Global E Online Ltd — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.20B), while Global E Online Ltd trades at $40.03 (market cap $6.54B). The key difference: Global E Online Ltd is far larger — about 5.5× Cronos Group Inc's market cap, and Cronos Group Inc is more actively traded (450,387 versus 1,011,873). Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Global E Online Ltd for 21 Days on average.
| CRON | GLBE | |
|---|---|---|
Market Cap | $1.20B | $6.54B |
Volume | 450,387 | 1,011,873 |
Sector | Health | Consumer Cyclical |
52-Week High | $3.55 | $42.36 |
52-Week Low | $2.30 | $27.54 |
Typical Hold Time | 22 Days | 21 Days |
Enterprise Value | $401.73M | $6.04B |
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.22, down 1.98% on the day, amid a bearish technical signal. The company reported mixed quarterly earnings but achieved record revenue and gross profit in Q2 2026, with net income turning positive. Recent investor day highlighted international expansion and cash flow focus. Valuation ratios show a P/E of 17.11 and P/S of 6.91, with strong net income margin of 39.08% projected for 2026.
Outlook is cautiously optimistic, driven by revenue growth and profitability improvements, but risks include cash flow volatility and competitive pressures. Analyst consensus is mixed with 60% hold rating. The stock's near-term performance hinges on execution of expansion plans and sustained earnings momentum.
GLBE trades at $38.96, up 0.67% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong Q2 2026 earnings, beating EPS estimates, and raised its full-year outlook, with revenue growth of 39% year-over-year. Recent news includes the appointment of Tomer Gold as Chief Revenue Officer and significant insider selling by executives.
The outlook is positive with robust analyst support—93% buy ratings and a $48.86 consensus price target implying 25% upside. Key risks include insider selling pressure and execution challenges in maintaining high growth. Earnings growth and margin expansion remain primary catalysts for stock appreciation.
Trailing returns across standard periods
Latest headlines on both assets
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →Global-e provides a platform for cross-border e-commerce, helping retailers increase international sales by localizing the shopping experience for consumers in over 200 destinations worldwide.
Read more on GLBE →